Fluence At
PS2023

Psychedelic Science 2023 Announces Supporting Sponsor Fluence

May 16th, 2022

Today, Psychedelic Science 2023, hosted by Multidisciplinary Association for Psychedelic Studies (MAPS) and organized by Momentum Events, announced that Fluence has joined the event as the first Supporting Sponsor.

With an estimated 10,000 attendees, Psychedelic Science 2023 will be the world’s largest gathering of the psychedelic ecosystem, taking place June 17-25, 2023 in Denver, Colorado and will feature three days of panels, workshops, and lectures from leaders and visionaries from psychedelic research, education, policy, business, culture, and communities. Conference tracks will be complemented by pre- and post-conference workshops; an exhibit hall; and a marketplace featuring artists, musicians, and other vendors from around the world.

“As psychedelic therapies emerge as the most promising psychiatric treatment modality in decades, there is an urgent need for accessible, widespread professional education about the safest and most effective ways to deliver them,” says Fluence co-founder Ingmar Gorman, Ph.D. “Fluence is proud to be the first Supporting Sponsor of Psychedelic Science 2023, and we are excited to support and attend this historic gathering.”

Attendees will include MAPS members, donors, researchers, students, clinicians, advocates, therapists, political leaders, entrepreneurs, executives, investors, psychedelic enthusiasts, and those who may benefit from MAPS’ decades of research and advocacy.

About Fluence

Founded in 2019 by Dr. Elizabeth Nielson and Dr. Ingmar Gorman—both of whom have served as Site Co-Principal Investigators in MAPS-sponsored clinical trials—Fluence is an expertise-driven educational platform that provides professional certification and training in psychedelic therapy and psychedelic integration for psychiatrists, psychotherapists, social workers, and other healthcare practitioners. Fluence’s mission is to give healthcare providers the clinical skills and knowledge to provide effective, compassionate, evidence-based psychedelic therapy and integration services to patients through dynamic, interactive online and in-person training.

About Momentum Events

Founded in 2012, Momentum Events proudly serves our clients and produces events that attract the best and brightest minds who come together to share their knowledge, connect with the individuals that matter most and enjoy valuable experiences online or in real life. Whether we’re developing cutting edge conferences for the markets we serve, or producing a partner’s next event, Momentum leverages our best in class technology platforms, an assortment of virtual and live event third-party provider relationships, and the meticulous nature of our event planning mindset to deliver true, sustainable value for all stakeholders. www.momentumevents.com

About MAPS

Founded in 1986, MAPS is a 501(c)(3) non-profit research and educational organization that develops medical, legal, and cultural contexts for people to benefit from the careful uses of psychedelics and marijuana. MAPS is sponsoring the most advanced psychedelic therapy research in the world: Phase 3 clinical trials of MDMA-assisted therapy for PTSD. Since MAPS was founded, philanthropic donors and grantors have given more than $130 million for psychedelic and marijuana research and education. MAPS has earned both the Guidestar Platinum Seal of Transparency and a 4-Star Rating from Charity Navigator.

Subscribe to the PS2023 newsletter to receive updates on our conference, speakers, events, and other important announcements.